Effect of Osseodensification on the Peri-implant Condition

Phase 2

Completed

• Conditions: Implant Therapy

• Registration Number: NCT06689969
• Lead Sponsor: Al-Azhar University

Brief Summary

The goal of this clinical trial is to evaluate the effects of osseodensification vs. traditional implant site preparation clinically , radiographically, bio-chemically. in patients of both sexes, ages 25 to 45, who had bilaterally missed maxillary teeth. The main questions it aims to answer are :which technique was the better results give at implant placement? Researchers will compare Osseodensification maneuver in implant placement to see if implant stability increased also peri-implant tissue accurately formed or the same in traditional implant site preparation. Participants will receiving dental implants in narrow maxillary posterior ridge via small diameter implant in conventional method in first entity while in second entity implant by osseodensification technique using densah bur.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-03
• Primary Completion: 2023-10-29
• Study Completion: 2024-03-15
• Status Verified: 2024-11
• Study First Submitted: 2024-11-13
• Study First Submitted QC: 2024-11-13
• Last Update Submitted: 2024-11-13
• Study First Posted: 2024-11-15
• Last Update Posted: 2024-11-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• All patients were free from any systemic diseases
• Individuals above age of 18 who have thin ridges and missing bilateral maxillary posterior teeth

Exclusion Criteria

• Severe skeletal discrepancy.
• Para functional habits.
• Patients who had already received or lost implants in the potential implantation site.
• Smoker patients.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Implant primary stability	A single time point (once immediately after implant placement)	Osstell® Mentor magnetic resonance instrument used to measure primary stability
Assessment of Vascular endothelial growth factor	[Time Frame: From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)]
Bone density	From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)	Measuring of bone density (BD) through using the image J analysis software application
Assessment of interleukin -6	From enrollment to the end of treatment at 24 weeks" (at the beginning, one, three-, and six-months following implant insertion)

Secondary Outcome Measures

Name	Time	Method
Peri-implant probing depth	From enrollment to the end of treatment at 24 weeks" (at the beginning, three-, and six-months following implant insertion)

Trial Locations

Locations (1)

Faculty of dental medicine, Al-Azhar University (Assiut branch); 🇪🇬 Assiut, Egypt